AtriCure Secures FDA Clearance for CryoFORM Cryoablation Probe

AtriCure, developer of atrial fibrillation treatments, has earned FDA clearance for its cryoFORM cryoablation probe, which is designed to adapt to a multitude of surgical ablation procedures.

The probe features thermal capacity to remove heat and active defrost and provides increased flexibility.

The device was launched in European markets under a CE mark in October 2015. — Anisa Jibrell